comparemela.com
  1. Home
  2. Live Updates
  3. Kevin Chung - Breaking News

Latest Breaking News On - Kevin chung - Page 7 : comparemela.com

SeaStar Medical (ICU) Announces FDA Grants its Selective Cytopheretic Device Breakthrough Device Designation for Hepatorenal Syndrome

SeaStar Medical (ICU) Announces FDA Grants its Selective Cytopheretic Device Breakthrough Device Designation for Hepatorenal Syndrome
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesEric schlorffKevin chungUniversity of michiganDrug administrationSeastar medical holding corporation nasdaqSeastar medical holding corporationBreakthrough device designationSelective cytopheretic deviceSeastar medicalChief medical officerAmerican societyArtificial internal organs journalBreakthrough device designationsBiologics evaluation

Baystreet ca - SeaStar Sails on FDA Nod

SeaStar Medical Holding Corporation (NASDAQ: ICU) shares enjoy upward momentum Friday. The medical device company announced receipt of U.S. Food and Drug Administration (FDA) Breakthrough DeviceDesignation for its patented, first-in-class, cell-directed .

United statesKevin chungUniversity of michiganSeastar medical holding corporationNational institutes of healthDrug administrationBreakthrough devicedesignationSelective cytopheretic deviceBreakthrough device designationBiologics evaluationChief medical officer kevinSeastar medicalBreakthrough deviceNational institutes

SeaStar Medical (ICU) Granted FDA Breakthrough Device Designation to Selective Cytopheretic Device for Cardiorenal Syndrome

SeaStar Medical (ICU) Granted FDA Breakthrough Device Designation to Selective Cytopheretic Device for Cardiorenal Syndrome
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesEric schlorffKevin chungUniversity of michiganDrug administrationSeastar medical holding corporation nasdaqNational institutes of healthSeastar medical holding corporationBreakthrough devicedesignationSelective cytopheretic deviceBreakthrough device designationBiologics evaluationChief medical officerSeastar medicalBreakthrough deviceNational institutes

SeaStar wins breakthrough nod for selective cytopheretic device

SeaStar Medical (Nasdaq:ICU) announced that the FDA granted breakthrough device designation for its selective cytopheretic device (SCD).

United statesEric schlorffKevin chungUniversity of michiganDenver based seastarSeastar medical

Baystreet ca - SeaStar Sails on FDA Nod

SeaStar Medical Holding Corporation (NASDAQ: ICU) shares enjoy upward momentum Friday. The medical device company announced receipt of U.S. Food and Drug Administration (FDA) Breakthrough DeviceDesignation for its patented, first-in-class, cell-directed .

United statesKevin chungUniversity of michiganSeastar medical holding corporationDrug administrationNational institutes of healthBreakthrough devicedesignationSelective cytopheretic deviceBreakthrough device designationBiologics evaluationChief medical officer kevinSeastar medicalBreakthrough deviceNational institutes

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.